185 related articles for article (PubMed ID: 27565680)
1. Transcriptional Regulation of Human Cytosolic Sulfotransferase 1C3 by Peroxisome Proliferator-Activated Receptor γ in LS180 Human Colorectal Adenocarcinoma Cells.
Dubaisi S; Fang H; Kocarek TA; Runge-Morris M
Mol Pharmacol; 2016 Nov; 90(5):562-569. PubMed ID: 27565680
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional Regulation of Cytosolic Sulfotransferase 1C2 by Vitamin D Receptor in LS180 Human Colorectal Adenocarcinoma Cells.
Barrett KG; Fang H; Kocarek TA; Runge-Morris M
Drug Metab Dispos; 2016 Aug; 44(8):1431-4. PubMed ID: 27130351
[TBL] [Abstract][Full Text] [Related]
3. Regulation of human cytosolic sulfotransferases 1C2 and 1C3 by nuclear signaling pathways in LS180 colorectal adenocarcinoma cells.
Rondini EA; Fang H; Runge-Morris M; Kocarek TA
Drug Metab Dispos; 2014 Mar; 42(3):361-8. PubMed ID: 24335393
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
5. Expression of the orphan cytosolic sulfotransferase SULT1C3 in human intestine: characterization of the transcript variant and implications for function.
Duniec-Dmuchowski Z; Rondini EA; Tibbs ZE; Falany CN; Runge-Morris M; Kocarek TA
Drug Metab Dispos; 2014 Mar; 42(3):352-60. PubMed ID: 24335392
[TBL] [Abstract][Full Text] [Related]
6. Switching subtype-selectivity: Fragment replacement strategy affords novel class of peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonists.
Shioi R; Okazaki S; Noguchi-Yachide T; Ishikawa M; Makishima M; Hashimoto Y; Yamaguchi T
Bioorg Med Chem Lett; 2017 Jul; 27(14):3131-3134. PubMed ID: 28539218
[TBL] [Abstract][Full Text] [Related]
7. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.
Takacs ML; Abbott BD
Toxicol Sci; 2007 Jan; 95(1):108-17. PubMed ID: 17047030
[TBL] [Abstract][Full Text] [Related]
8. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
Park EY; Cho IJ; Kim SG
Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
[TBL] [Abstract][Full Text] [Related]
9. The human semaphorin 6B gene is down regulated by PPARs.
Collet P; Domenjoud L; Devignes MD; Murad H; Schohn H; Dauça M
Genomics; 2004 Jun; 83(6):1141-50. PubMed ID: 15177567
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor.
Fang HL; Strom SC; Cai H; Falany CN; Kocarek TA; Runge-Morris M
Mol Pharmacol; 2005 Apr; 67(4):1257-67. PubMed ID: 15635043
[TBL] [Abstract][Full Text] [Related]
11. Human mannose-binding lectin 2 is directly regulated by peroxisome proliferator-activated receptors via a peroxisome proliferator responsive element.
Tachibana K; Takeuchi K; Inada H; Sugimoto K; Ishimoto K; Yamashita M; Maegawa T; Yamasaki D; Osada S; Tanaka T; Rakugi H; Hamakubo T; Sakai J; Kodama T; Doi T
J Biochem; 2013 Sep; 154(3):265-73. PubMed ID: 23711995
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.
Röhrl C; Kaindl U; Koneczny I; Hudec X; Baron DM; König JS; Marian B
J Cancer Res Clin Oncol; 2011 Jan; 137(1):29-39. PubMed ID: 20221637
[TBL] [Abstract][Full Text] [Related]
13. Three peroxisome proliferator-activated receptor isotypes from each of two species of marine fish.
Leaver MJ; Boukouvala E; Antonopoulou E; Diez A; Favre-Krey L; Ezaz MT; Bautista JM; Tocher DR; Krey G
Endocrinology; 2005 Jul; 146(7):3150-62. PubMed ID: 15790725
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma regulates expression of signal transducer and activator of transcription 5A.
Olsen H; Haldosén LA
Exp Cell Res; 2006 May; 312(8):1371-80. PubMed ID: 16457814
[TBL] [Abstract][Full Text] [Related]
15. In vivo imaging reveals selective PPAR activity in the skin of peroxisome proliferator-activated receptor responsive element-luciferase reporter mice.
El-Jamal N; Dubuquoy L; Auwerx J; Bertin B; Desreumaux P
Exp Dermatol; 2013 Feb; 22(2):137-40. PubMed ID: 23362873
[TBL] [Abstract][Full Text] [Related]
16. Citrate carrier promoter is target of peroxisome proliferator-activated receptor alpha and gamma in hepatocytes and adipocytes.
Damiano F; Gnoni GV; Siculella L
Int J Biochem Cell Biol; 2012 Apr; 44(4):659-68. PubMed ID: 22249025
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present).
Takada I; Makishima M
Expert Opin Ther Pat; 2020 Jan; 30(1):1-13. PubMed ID: 31825687
[No Abstract] [Full Text] [Related]
18. An intact DNA-binding domain is not required for peroxisome proliferator-activated receptor gamma (PPARgamma) binding and activation on some PPAR response elements.
Temple KA; Cohen RN; Wondisford SR; Yu C; Deplewski D; Wondisford FE
J Biol Chem; 2005 Feb; 280(5):3529-40. PubMed ID: 15572375
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptors-α and -γ, and cAMP-mediated pathways, control retinol-binding protein-4 gene expression in brown adipose tissue.
Rosell M; Hondares E; Iwamoto S; Gonzalez FJ; Wabitsch M; Staels B; Olmos Y; Monsalve M; Giralt M; Iglesias R; Villarroya F
Endocrinology; 2012 Mar; 153(3):1162-73. PubMed ID: 22253419
[TBL] [Abstract][Full Text] [Related]
20. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
